USFDA inspections back in full swing for Pharma Companies

USFDA plant inspections seem to be coming back strongly after a two-year hiatus, going by the just-concluded inspection at Zydus Lifesciences on March 10 and a warning letter to Aurobindo earlier this year, in mid-January.

USFDA officials commented in February 2022 that USFDA is keen on restarting pharma companies inspections, including surprise inspections in India.

USFDA could be set for a busy year in India as the backlog of redressals from previous inspections and pending applications for plants and products become pressing.

Earlier, the total number of USFDA plant audits for drug quality assurance in India peaked in 2019 at 239.

Another 80 inspections were completed in January-March 2020 prior to Covid and slid to 5 inspections in 2021.

The surge in audit inspections could be periodic or could also be linked to evolving standards in manufacturing.

Related Posts

  • Pharma
  • June 26, 2025
  • 83 views
Chemotherapy drugs made by Indian firms fail quality tests, shows study

Vital chemotherapy drugs used around the world have failed quality tests, leaving cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, the Bureau of…

  • Pharma
  • June 26, 2025
  • 112 views
Hundreds of weight loss and diabetes jab users report pancreas problems

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to launch a study into side-effects. Some cases of pancreatitis…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Most Advanced Cancer Care is New Chapter @ Sir Ganga Ram

Most Advanced Cancer Care is New Chapter @ Sir Ganga Ram

Chemotherapy drugs made by Indian firms fail quality tests, shows study

Chemotherapy drugs made by Indian firms fail quality tests, shows study

Hundreds of weight loss and diabetes jab users report pancreas problems

Hundreds of weight loss and diabetes jab users report pancreas problems

Act on Cataract now with Next Generation Technology to keep Blindness at bay

Act on Cataract now with Next Generation Technology to keep Blindness at bay